Collegium Pharmaceutical has tapped an appropriately glitzy star as the face of a new campaign spotlighting the bright side of life with attention-deficit/hyperactivity disorder (ADHD).
Paris Hilton, who uses Collegium’s Jornay PM to manage her ADHD symptoms, is heading up the “Embrace Your Sparkle” initiative, in which she’s sharing her own experiences with ADHD to encourage more open and understanding conversations and a reduction in the societal stigma attached to the condition.
The campaign, housed on the Jornay PM website, details Hilton’s story, in which finally receiving an ADHD diagnosis not only explained the heiress’s lifelong struggles with focus and attention but also helped her recognize the unique outlook and creativity that it has given her—as she previously described in her 2024 song “ADHD.”
“I’ve learned to look at ADHD from a different perspective,” Hilton said in Tuesday’s announcement unveiling the campaign. “‘Embrace Your Sparkle’ reminds me that ADHD can be a source of creativity and courage.”
With those benefits, and especially while juggling life as an entrepreneur and mother of two, Hilton said she chose to talk to her doctor about a treatment that could help manage her symptoms.
“The day-to-day challenges of ADHD symptoms are very real,” she continued in the statement. “There are days when balancing motherhood, music, and work feels overwhelming, and I know so many people can relate to that.”
Hilton and her doctor ultimately landed on Jornay PM, which is taken at night so that it has already begun working to control ADHD symptoms by the time users wake up the next morning.
The new campaign comes shortly after Collegium unveiled another ADHD-focused initiative.
Just last week, the company announced a multiyear team-up with Boston Legacy FC, the professional women’s soccer team slated to make its official debut this month. Collegium will serve as sponsor of a dedicated “sensory room” at the team’s arena.
Designed with input from the nonprofit organization Children and Adults with Attention-Deficit/Hyperactivity Disorder, the room will offer a quiet, comfortable space for visitors who may experience sensory sensitivities or sensory regulation challenges, which can affect people with ADHD as well as those with autism, dementia, post-traumatic stress disorder and more.